← Back to Analyst Consensus 
IMMX Buy
Immix Biopharma, Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 29, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Sep 15, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Aug 11, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 10, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 22, 2026 | Needham | initiate | — → Buy | — | 50% |
| Jun 18, 2026 | B of A Securities | initiate | — → Buy | — | 53% |
| Jun 17, 2026 | LifeSci Capital | initiate | — → Outperform | — | 57% |
| May 22, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 30, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 30, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Mar 27, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 46% |
| Mar 27, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 25, 2026 | Morgan Stanley | initiate | — → Overweight | — | 54% |
| Mar 9, 2026 | Citizens | initiate | — → Market Outperform | — | 46% |
| Feb 9, 2026 | Mizuho | initiate | — → Outperform | $14 | 52% |
| Dec 9, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Sep 12, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $8 | 44% |
| Jun 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Feb 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jan 6, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Oct 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Aug 19, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jul 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jul 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jul 1, 2024 | HC Wainwright & Co. | initiate | — → Buy | $7 | 44% |
| Aug 14, 2023 | Roth MKM | reiterate | Buy → Buy | $14 | 52% |
| Feb 22, 2023 | Roth MKM | initiate | — → Buy | $14 | 52% |
Price Target Trend
Apr 21, 2026 Latest: $24.43 Oct 24, 2026
EPS Estimates
+1q $-0.20
Lo: $-0.26 Hi: $-0.17
7 analysts ▲1
0q $-0.19
Lo: $-0.21 Hi: $-0.17
7 analysts 0y $-0.72
Lo: $-0.80 Hi: $-0.51
8 analysts ▲2
+1y $-0.95
Lo: $-1.45 Hi: $-0.20
8 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days